Overview

Insight Kids Study: Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes

Status:
Recruiting

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

This study is to compare metabolic control, treatment satisfaction, and quality of life during continuous subcutaneous insulin infusion (CSII ) therapy with a new insulin pump system with multiple daily injections (MDI) therapy. Furthermore, this study will add clinical data originating from clinical investigation in a special population, i.e. children and adolescents, to the existing clinical data of the ACCU-CHEK Insight insulin pump.

Phase:

Phase 4

Details

Lead Sponsor:

Hoffmann-La Roche

Collaborator:

Roche Diabetes Care GmbH

Treatments:

Insulin
Insulin, Globin Zinc